Multiple Sclerosis
Accurately visualize lesion and brain volume changes over time in multiple sclerosis
icobrain ms
icobrain ms is designed to support the detection and tracking of disease progression, and the evaluation of treatment effectiveness.
It provides a quantitative analysis of the inflammatory component of the disease, assessing longitudinal changes in FLAIR and T1 lesions. Additionally, icobrain ms can be used to assess changes in brain volume over time, which can be compared to age- and sex-matched healthy individuals.
icobrain ms+
icobrain ms+ (only available for research) can be used to evaluate the central vein sign and paramagnetic rim lesions based on susceptibility-weighted imaging, and additional brain volumes, and cross-sectional surface area of the C2-C3 section of the cervical spinal cord from T1-w images.
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
What we often miss in following MS patients is subtle changes that take place over the course of many years. If you are not ordering icobrain for your MS patients, you may be leaving important information on the table.
Tiron Pechet, Radiologist at Shields Healthcare Group
150%
Increased detection of disease activity in MS
2.5x
Faster detection of treatment failure
68%
outcome improvement when employing icobrain® vs drugs alone
With icobrain, we can provide a technologic level of observation that previously has only been available for centers in clinical trials. Now, every patient can be measured this way, can be assessed, and we are using this data to make important changes in our day-to-day patient management.
With icobrain, we can provide a technologic level of observation that previously has only been available for centers in clinical trials. Now, every patient can be measured this way, can be assessed, and we are using this data to make important changes in our day-to-day patient management.
Stanley Cohan, Neurologist at Providence
.png)
.png)
.png)
.png)
.png)
.png)